Alzheon to Present Biomarker, Brain Preservation, and Clinical Results from Pivotal Program of Oral ALZ-801/Valiltramiprosate at International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders | Region
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Feb 27, 2024--
Source: eagletribune.com